Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
Human medicines: European public assessment reports (EPARs)
Get the latest updates from Human medicines: European public assessment reports (EPARs) directly as they happen.
Follow now 130 followers
Latest posts
Last updated 1 day ago
Human medicines European public assessment report (EPAR): Rivastigmine Hexal, rivastigmine, Dementia;Alzheimer Disease;Parkinson Disease, Date of authorisation: 11/12/2009, Revision: 12, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Rivastigmine Hexal, rivastigmine, Dementia;Alzheimer Disease;Parkinson...
Human medicines European public assessment report (EPAR): Byetta, exenatide, Diabetes Mellitus, Type 2, Date of authorisation: 20/11/2006, Revision: 26, Status: Authorised
2 days ago
Human medicines European public assessment report (EPAR): Byetta, exenatide, Diabetes Mellitus, Type...
Human medicines European public assessment report (EPAR): Abasaglar (previously Abasria), insulin glargine, Diabetes Mellitus, Date of authorisation: 09/09/2014, Revision: 12, Status: Authorised
2 days ago
Human medicines European public assessment report (EPAR): Abasaglar (previously Abasria), insulin glargine...
Human medicines European public assessment report (EPAR): Hepcludex, bulevirtide, Hepatitis D, Chronic, Date of authorisation: 31/07/2020, Revision: 4, Status: Authorised
2 days ago
Human medicines European public assessment report (EPAR): Hepcludex, bulevirtide, Hepatitis D, Chronic...
Human medicines European public assessment report (EPAR): Rivastigmine 1 A Pharma, rivastigmine, Alzheimer Disease;Dementia;Parkinson Disease, Date of authorisation: 11/12/2009, Revision: 11, Status: Authorised
2 days ago
Human medicines European public assessment report (EPAR): Rivastigmine 1 A Pharma, rivastigmine...
Human medicines European public assessment report (EPAR): Harvoni, ledispavir,sofosbuvir, Hepatitis C, Chronic, Date of authorisation: 17/11/2014, Revision: 23, Status: Authorised
3 days ago
Human medicines European public assessment report (EPAR): Harvoni, ledispavir,sofosbuvir, Hepatitis C, Chronic...
Human medicines European public assessment report (EPAR): Viagra, sildenafil, Erectile Dysfunction, Date of authorisation: 13/09/1998, Revision: 37, Status: Authorised
3 days ago
Human medicines European public assessment report (EPAR): Viagra, sildenafil, Erectile Dysfunction, Date...
Human medicines European public assessment report (EPAR): Parsabiv, etelcalcetide, Hyperparathyroidism, Secondary, Date of authorisation: 11/11/2016, Revision: 9, Status: Authorised
3 days ago
Human medicines European public assessment report (EPAR): Parsabiv, etelcalcetide, Hyperparathyroidism, Secondary, Date...
Human medicines European public assessment report (EPAR): Cystadane, betaine anhydrous, Homocystinuria, Date of authorisation: 14/02/2007, Revision: 14, Status: Authorised
3 days ago
Human medicines European public assessment report (EPAR): Cystadane, betaine anhydrous, Homocystinuria, Date...
Human medicines European public assessment report (EPAR): Fiasp, insulin aspart, Diabetes Mellitus, Date of authorisation: 09/01/2017, Revision: 8, Status: Authorised
3 days ago
Human medicines European public assessment report (EPAR): Fiasp, insulin aspart, Diabetes Mellitus...
Human medicines European public assessment report (EPAR): Glyxambi, empagliflozin,linagliptin, Diabetes Mellitus, Type 2, Date of authorisation: 11/11/2016, Revision: 12, Status: Authorised
3 days ago
Human medicines European public assessment report (EPAR): Glyxambi, empagliflozin,linagliptin, Diabetes Mellitus, Type...
Human medicines European public assessment report (EPAR): Onbrez Breezhaler, indacaterol, Pulmonary Disease, Chronic Obstructive, Date of authorisation: 29/11/2009, Revision: 17, Status: Authorised
3 days ago
Human medicines European public assessment report (EPAR): Onbrez Breezhaler, indacaterol, Pulmonary Disease...